Anti-Diabetic Drug Gliclazide 99% CAS: 21187-98-4 Gliclazide

Model NO.
TGY202306130703
Service
OEM
Grade
Pharmaceutical Grade
MOQ
Any Quantitiy
Sample
Available
Shelf Life
24 Months Properly
Certificate
ISO9001:2008
Storage
Cool Dry Area
Test Method
USP;GMP
Molecular Weight
323.41
Molecular Formula
C15h21n3o3s
Coa
Available
Assay
99%
Product Name
Gliclazide
CAS No.
21187-98-4
Appearance
White Powder
Transport Package
Boil Bag
Specification
HPLC 99%
Trademark
TGY
Origin
Xi′an, Shaanxi, China (Mainland)
HS Code
29225090
Production Capacity
5000kg/Month
Reference Price
$ 85.50 - 99.00
Contact Us

Product Description

Anti-Diabetic Drug Gliclazide 99% CAS: 21187-98-4 Gliclazide Anti-Diabetic Drug Gliclazide 99% CAS: 21187-98-4 Gliclazide

Product Name Gliclazide 
CAS No. 21187-98-4
Melting point  163-169 °C (lit.)
density  1.2205 (rough estimate)
refractive index  1.6740 (estimate)
storage temp.  2-8°C
pka 6.07±0.10(Predicted)
Appearance White powder
Grade Pharmaceutical Grade

Gliclazide is a 2nd generation oral sulfonylurea hypoglycemic agent with strong action. Its mechanism is similar to that of toluenosulfonylurea, i.e., it selectively acts on pancreatic β-cells to promote insuln secretion and enhance insuln release after eating glucose, which can not only improve the metabolism of diabetic patients, but also improve or delay the occurrence of diabetic vascular complications.

Anti-Diabetic Drug Gliclazide 99% CAS: 21187-98-4 Gliclazide

Gliclazide is mainly used for mild and moderate type II diabetes mellitus with adult-onset where diet and exercise control alone are ineffective and without a tendency to ketosis, and also improves fundus lesions and metabolic and vascular dysfunctions in diabetic patients.
Anti-Diabetic Drug Gliclazide 99% CAS: 21187-98-4 Gliclazide

1. For adults with type 2 diabetes, diabetes associated with obesity or vascular lesions.
2. Hypoglycemic agents. It can be used for the treatment of non-insuln dependent diabetes mellitus.

 

Pharmaceutical Intermediate

GOUV.NE, 2023